<DOC>
	<DOCNO>NCT00989157</DOCNO>
	<brief_summary>This study aim determine difference , , pharmacokinetics duloxetine patient nine fifteen month post Roux-en-Y Bariatric Surgery control subject match body mass index ( BMI ) , age gender .</brief_summary>
	<brief_title>Effects Gastric Bypass Blood Levels Duloxetine</brief_title>
	<detailed_description />
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Male female subject age 18 60 year . Subjects must good general health history physical exam . Ten experimental subject 9 15 month post bariatric surgery ( RouxenY procedure ) , BMI requirement . Ten normal control subject meet inclusion criterion receive bariatric surgery match surgery subject accord body mass index , age sex . Women child bear potential must practice accepted method birth control ( barrier method oral contraceptive ) negative pregnancy test baseline . No contraindication receive single capsule 60 mg duloxetine Allergy duloxetine constituent . Candidates pregnant nursing Candidates currently receive antidepressant . Candidates determine poor metabolizers CYP2D6 Subjects smoke use nicotine product Candidates currently receive medication interacts duloxetine . Candidates experience clinically significant , unstable neurological , hepatic , renal cardiovascular disease . Candidates experience history vomit diarrhea associate bariatric surgery Candidates currently past history meeting DSMIV diagnostic criterion schizophrenia , schizoaffective disorder , bipolar disorder . Candidates participate investigational drug study past 30 day . Candidates meet DSMIV diagnostic criterion drug/alcohol abuse dependency history drug/alcohol abuse dependency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Gastric Bypass</keyword>
	<keyword>Duloxetine</keyword>
	<keyword>Cymbalta</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>